Stevanato Group Q3 EPS Estimate Boosted by William Blair

Key Points

• William Blair raised its Q3 2026 earnings estimate for Stevanato Group to $0.19 per share, up from $0.18, maintaining an "Outperform" rating for the stock.
• Stevanato Group received a "strong-buy" rating from Stephens and currently holds a consensus rating of "Moderate Buy" with a price target of €25.70 ($29.88).
• The stock has recently added several institutional investors and displayed a market capitalization of $7.39 billion with a PE ratio of 45.17.

Stevanato Group S.p.A. (NYSE:STVN - Free Report) - Equities researchers at William Blair boosted their Q3 2026 earnings estimates for shares of Stevanato Group in a report issued on Wednesday, August 6th. William Blair analyst M. Larew now forecasts that the company will earn $0.19 per share for the quarter, up from their prior forecast of $0.18. William Blair has a "Outperform" rating on the stock. The consensus estimate for Stevanato Group's current full-year earnings is $0.50 per share. William Blair also issued estimates for Stevanato Group's FY2026 earnings at $0.74 EPS.

Separately, Stephens raised shares of Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of €25.13 ($29.22).

Stevanato Group Stock Down 4.7%

Shares of NYSE STVN traded down €1.11 ($1.29) during mid-day trading on Thursday, reaching €22.52 ($26.19). The company had a trading volume of 165,411 shares, compared to its average volume of 338,455. The company has a current ratio of 1.79, a quick ratio of 1.22 and a debt-to-equity ratio of 0.25. The firm has a 50 day simple moving average of €24.52 and a two-hundred day simple moving average of €22.44. The stock has a market cap of $6.82 billion, a P/E ratio of 41.70, a PEG ratio of 2.23 and a beta of 0.55. Stevanato Group has a 52-week low of €17.12 ($19.91) and a 52-week high of €28.00 ($32.56).

Institutional Trading of Stevanato Group

Large investors have recently bought and sold shares of the business. Whittier Trust Co. acquired a new stake in Stevanato Group during the 1st quarter valued at $27,000. Twin Tree Management LP acquired a new position in Stevanato Group in the first quarter valued at approximately $29,000. Johnson Financial Group Inc. acquired a new position in shares of Stevanato Group during the fourth quarter worth approximately $41,000. SVB Wealth LLC bought a new stake in Stevanato Group during the first quarter worth $46,000. Finally, Van Berkom & Associates Inc. grew its stake in Stevanato Group by 33.3% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock valued at $49,000 after purchasing an additional 600 shares during the period.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.